PROMETHEUS BIOSCIENCES, INC.

Profile

Company Names

PROMETHEUS BIOSCIENCES, INC.
PRECISION IBD, INC.

Addresses

9410 CARROLL PARK DRIVE, SAN DIEGO, CA 92121

3525 DEL MAR HEIGHTS ROAD #342, SAN DIEGO, CA 92130

1496 NEPTUNE AVENUE, ENCINITAS, CA 92024

Phone Numbers

858-824-0895
619-987-7768

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$111,839,507.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-10-30 
$50,000,000.00 
$130,000,000.00 
$80,000,000.00 
Equity 
3
2019-06-30 
$48,063,500.00 
$60,000,000.00 
$11,936,500.00 
Equity 
2
2018-11-14 
$10,086,407.00 
$20,000,000.00 
$9,913,593.00 
Equity 
1
2017-09-26 
$3,689,600.00 
$10,000,000.00 
$6,310,400.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
BEHAR 
DIRECTOR
PRONUTRIA BIOSCIENCES, INC.   |  AXCELLA HEALTH INC.   |  AIMMUNE THERAPEUTICS, INC.   |  PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  SONOVA HOLDING AG
ROLF 
J. 
BENIRSCHKE 
DIRECTOR
PRECISION IBD, INC.
THIERRY 
 
DERVIEUX, PHARM D., PH.D. 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.
JOY 
 
GHOSH, PH.D. 
DIRECTOR
PROMETHEUS BIOSCIENCES, INC.
SCOTT 
L. 
GLENN 
EXECUTIVE OFFICER, DIRECTOR
EVOKE PHARMA INC   |  EXAGEN DIAGNOSTICS INC   |  SELEXAGEN THERAPEUTICS, INC.   |  KALYRA PHARMACEUTICALS, INC.   |  TOKALAS, INC.   |  ALASTIN SKINCARE, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  PRECISION IBD, INC.   |  VELOSBIO INC.   |  REBALANCE HEALTH, INC.
MARTIN 
 
HENDRIX, PH.D. 
DIRECTOR
PROMETHEUS BIOSCIENCES, INC.
LAURENS 
 
KRUIDENIER, PH.D. 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.
JAMES 
 
LAUR 
DIRECTOR
GEMELLI BIOTECH CORP.   |  PROMETHEUS BIOSCIENCES, INC.
JAMES 
D. 
LAUR 
DIRECTOR
PROMETHEUS BIOSCIENCES, INC.
ALLISON 
 
LUO, M.D. 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.
KEITH 
W. 
MARSHALL, PH.D. 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.
MARK 
 
MCKENNA 
EXECUTIVE OFFICER, DIRECTOR
LIFENEXUS, INC.   |  SE HOLDING CORP.   |  PROMETHEUS BIOSCIENCES, INC.
SHLOMO 
 
MELMED 
DIRECTOR
EMULATE, INC.   |  QUANTAVERSE LLC   |  PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  VISBY MEDICAL, INC.
LAUREN 
 
OTSUKI 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.   |  GLO PHARMA, INC.   |  EVIDA BIOSCIENCES INC.   |  SRT THERAPEUTICS, INC.
LAUREN 
G. 
OTSUKI 
EXECUTIVE OFFICER
SELEXAGEN THERAPEUTICS, INC.   |  TOKALAS, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  PROMETHEUS BIOSCIENCES, INC.
JOSEPH 
C. 
PAPA 
DIRECTOR
PROMETHEUS BIOSCIENCES, INC.
GERALD 
T. 
PROEHL 
DIRECTOR
DERMATA THERAPEUTICS, LLC   |  MDREJUVENA, INC.   |  PRECISION IBD, INC.   |  TENAX THERAPEUTICS, INC.   |  DERMATA THERAPEUTICS, INC.
WILLIAM 
 
SANDBORN, M.D. 
DIRECTOR
PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.
CHRIS 
 
SLAVINSKY 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.
MARK 
 
STENHOUSE 
DIRECTOR
PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.
ADAM 
 
STONE 
DIRECTOR
PM ACQUISITION LLC   |  RENOVIA INC.   |  SOLID BIOSCIENCES INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  D. TOOLS INC.   |  SPEEDLANCER INC.   |  ADU OZ FUND LLC
STEPHAN 
 
TARGAN 
DIRECTOR
PRECISION IBD, INC.
DOUGLAS 
 
WALL 
DIRECTOR
TECH M3, INC.   |  SELECT ENERGY SERVICES, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  GLO PHARMA, INC.   |  CIRCA SCIENTIFIC, INC.   |  VIROMISSILE, INC.
DOUGLAS 
F. 
WALL 
DIRECTOR
PRECISION IBD, INC.   |  LIFE VENTURES LEGACY, LP
MIKE 
 
WALTHER 
EXECUTIVE OFFICER
PROMETHEUS BIOSCIENCES, INC.   |  ISOTHRIVE INC.
SHIERLEY 
 
WIDJAJA 
DIRECTOR
PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  AVENZOAR PHARMACEUTICALS, INC.   |  EVIDA BIOSCIENCES INC.   |  SRT THERAPEUTICS, INC.
TADATAKA 
 
YAMADA 
DIRECTOR
OUTPOST MEDICINE, LLC   |  RODEO THERAPEUTICS CORP   |  SCOUT BIO, INC.   |  PRECISION IBD, INC.   |  ATHIRA PHARMA, INC.   |  PASSAGE BIO, INC.
TADATAKA 
 
YAMADA, M.D. 
DIRECTOR
PRECISION IBD, INC.   |  ICOSAVAX, INC.   |  PROMETHEUS BIOSCIENCES, INC.
TADATAKA 
TACHI 
YAMADA, M.D. 
DIRECTOR
PROMETHEUS BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-11-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
2020-04-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-30 
2019-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-30 
2018-11-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-14 
2017-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#